These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28608802)

  • 21. Effects of dicalcium silicate coating ionic dissolution products on human mesenchymal stem-cell proliferation and osteogenic differentiation.
    Li HW; Sun JY
    J Int Med Res; 2011; 39(1):112-28. PubMed ID: 21672314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of osteogenic differentiation in stromal cells of giant cell tumour of bone by zoledronic acid.
    Yang T; Zheng XF; Li M; Lin X; Yin QS
    Asian Pac J Cancer Prev; 2013; 14(9):5379-83. PubMed ID: 24175830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
    von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
    Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis.
    Luo Z; Liu M; Sun L; Rui F
    Mol Med Rep; 2015 Jul; 12(1):382-8. PubMed ID: 25695835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis.
    Catalano A; Morabito N; Basile G; Brancatelli S; Cucinotta D; Lasco A
    J Clin Endocrinol Metab; 2013 May; 98(5):1911-5. PubMed ID: 23596142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation.
    Lacey DC; Simmons PJ; Graves SE; Hamilton JA
    Osteoarthritis Cartilage; 2009 Jun; 17(6):735-42. PubMed ID: 19136283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silibinin promotes osteoblast differentiation of human bone marrow stromal cells via bone morphogenetic protein signaling.
    Ying X; Sun L; Chen X; Xu H; Guo X; Chen H; Hong J; Cheng S; Peng L
    Eur J Pharmacol; 2013 Dec; 721(1-3):225-30. PubMed ID: 24076187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis.
    Gatti D; Viapiana O; Idolazzi L; Fracassi E; Ionescu C; Dartizio C; Troplini S; Kunnathully V; Adami S; Rossini M
    Bone; 2014 Oct; 67():189-92. PubMed ID: 25003812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the osteogenic differentiation of human mesenchymal stromal cells by the synergistic action of growth factors.
    Açil Y; Ghoniem AA; Wiltfang J; Gierloff M
    J Craniomaxillofac Surg; 2014 Dec; 42(8):2002-9. PubMed ID: 25458345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation.
    Ye X; Huang H; Zhao N; Zhang J; Yang P
    In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1026-1033. PubMed ID: 27401008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoledronic acid for cancer therapy--induced and postmenopausal bone loss.
    Brufsky AM
    Expert Opin Pharmacother; 2008 Apr; 9(6):1013-28. PubMed ID: 18377343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
    Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of BMP-2 and FGF2 on the osteogenesis of bone marrow-derived mesenchymal stem cells in hindlimb-unloaded rats.
    Qian X; Zhang C; Chen G; Tang Z; Liu Q; Chen J; Tong X; Wang J
    Cell Biochem Biophys; 2014 Nov; 70(2):1127-36. PubMed ID: 24880437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating runx2.
    Sun J; Zhou H; Deng Y; Zhang Y; Gu P; Ge S; Fan X
    Cells Tissues Organs; 2012; 196(6):510-22. PubMed ID: 22906827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginkgo biloba extract promotes osteogenic differentiation of human bone marrow mesenchymal stem cells in a pathway involving Wnt/β-catenin signaling.
    Gu Q; Chen C; Zhang Z; Wu Z; Fan X; Zhang Z; Di W; Shi L
    Pharmacol Res; 2015 Jul; 97():70-8. PubMed ID: 25917209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro.
    Chen C; Uludağ H; Wang Z; Jiang H
    J Cell Biochem; 2012 Dec; 113(12):3672-80. PubMed ID: 22740073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
    Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
    Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
    Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
    Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
    Middleton ET; Steel SA; Aye M; Doherty SM
    J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.